Skip to content
zameds

Clonidine Hydrochloride Lennon

Clonidine

Every registration of this product has been cancelled.

Loading the molecular structure
C9H9Cl2N3230.09 g/mol

N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 2803.

Registration

Applicants
1
Registrations
2

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Pharmacare limited û woodmeadCancelledClonidine hydrochloride lennon150 mcg -, 300 mcg -M0060, M0061Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Clonidine hydrochloride tablets 150 MCG - lennon

EACH TABLET CONTAINS CLONIDINE HYDROCHLORIDE 150 mcg

150 mcg -TabletsM0060M/7.1.3/60CancelledNot determinedNone
Clonidine hydrochloride tablets 300 MCG - lennon

EACH TABLET CONTAINS CLONIDINE HYDROCHLORIDE 300 mcg

300 mcg -TabletsM0061M/7.1.3/61CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Clonidine

    • except when intended for the prevention of migraine.

    Consolidated Schedules 06 July 2026, line 3340

  • S2: Clonidine

    • when intended for the prevention of migraine.

    Consolidated Schedules 06 July 2026, line 1756

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles